Urano and Pegasus Receive Shareholder and Court Approval for Acquisitions by Aero; Name Change to Manhattan Uranium Discovery Corp. Effective May 7, 2026

Aero Energy announced that shareholders of both Urano Energy and Pegasus Resources approved the proposed acquisitions at special meetings on April 29, 2026. Urano shareholders backed the arrangement with 99.91% approval, while Pegasus shareholders approved it with 98.21%, clearing a key step for the transactions. The update is constructive for deal completion but is largely procedural and likely to have limited near-term market impact.

Analysis

This clears the main binary overhang on the roll-up and shifts the story from deal risk to execution risk. The market should now start pricing the acquirer less like a pure exploration microcap and more like a capital-allocation vehicle with optionality across three assets, which can compress the governance discount if the combined equity becomes more liquid and institutionally ownable. That said, approval at the shareholder level often marks the point where the easy part is done; the real value creation depends on whether Aero can integrate the assets without issuing repeated equity to fund them.

Second-order, the biggest beneficiary may be not the target holders but the post-close float dynamics in AERO/AAUGF. If the arrangements close cleanly, legacy holders of the acquired names become forced sellers or index-less holders into a potentially thinner parent vehicle, which can create temporary dislocations and improve trading setups around the effective date. Competitors in the same grassroots/resource corridor may also face a relative valuation reset if Aero uses the combined platform to re-rate from “single-asset lottery ticket” to “portfolio builder.”

The key risk is that shareholder approval is not the same as cash-flowing asset quality; if the market concludes this is primarily a paper consolidation, the post-close pop can fade within days to weeks. The most important catalyst now is timing to final court/closing milestones, because deal spreads in small-cap Canadian names can re-widen sharply if there is any slippage. Over months, the upside case depends on whether management can demonstrate a credible post-close exploration spend plan without diluting existing holders.

Contrarian view: consensus may be underestimating how much of the move is already in the stock. High approval rates reduce break risk, but they also remove uncertainty that previously supported the spread, so a textbook “buy the rumor, sell the news” reaction is plausible. If liquidity stays poor, even positive fundamentals may not translate into sustained price appreciation unless the company pairs closing with a substantive operational update.

Key Decisions for Investors

• Long AERO into final closing, but only as a short-dated event trade over the next 2-6 weeks; target a spread capture/rerating, and trim aggressively if the stock gaps higher on no new operational information.
• Avoid chasing AAUGF post-approval; if you own it, use strength to rotate into AERO because the cleaner post-close capital structure should capture any re-rating over the next 1-3 months.
• Pair trade: long AERO / short a basket of comparable Canadian microcap explorers over the next 1-2 months to isolate reduced deal-risk and potential liquidity re-rating; exit if closing slips or dilution language emerges.
• If options are unavailable, size this as a tactical position only: max 1/2 normal risk because the upside is event-driven while downside remains tied to financing and integration uncertainty.